Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


A study investigating the safety of Tysabri in patients with early relapsing-remitting MS has been presented at the 2016 meeting of the Consortium of Multiple Sclerosis Centres (CMSC). Previous...
Community-based tai chi has been linked to improvements in endurance, strength, fatigue, and balance in a small group of patients with multiple sclerosis (MS), according a new study. Because tai chi...
A study claims newly diagnosed patients with relapsing-remitting multiple sclerosis (RRMS) showed significant improvements when treated with delayed-release dimethyl fumarate (DMF), especially in...
Researchers at Johns Hopkins University in Baltimore say they have found that visual function in multiple sclerosis (MS) patients correlates with cognitive function, suggesting disease severity and...
Multiple sclerosis risk is lower in HIV-infected patients, according to a new study. The association apparently comes from the chronic dampening down of the immune system associated with HIV, along...
Scientists have for the first time found a gene that can be linked directly to the development of multiple sclerosis (MS). While about 10 to 15 per cent of MS cases appear to have a hereditary...
Researchers at the University of Technology Sydney (UTS) say they are planning to explore the anti-inflammatory potential of a controlled infection by parasitic worms as a way of preventing the over-...
Data from an extension phase of a Phase III clinical trial claims the biotin MD1003 showed effectiveness over time as a possible treatment of non-active, progressive multiple sclerosis (MS). The data...
The Russian Ministry of Health has granted Marketing Authorisation to R-Pharm JSC for the development of Glatirat, a drug intended for the treatment of patients with relapsing-remitting multiple...
US patients with multiple sclerosis could soon gain access to a new treatment option after the US Food and Drug Administration approved Biogen and AbbVie's once-monthly, self-administered injection...

Pages